Wells Fargo Downgrades MEI Pharma To Market Perform

By: via Benzinga
Analysts at Wells Fargo downgraded MEI Pharma, Inc. (NASDAQ: MEIP) from Outperform to Market Perform. MEI Pharma shares have dropped ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.